The Archive · 3 posts
Driving innovation in precision medicine! 🚀 Diaceutics PLC (DXRX) revolutionises healthcare by boosting diagnostic testing strategies worldwide. 🌍
Diaceutics grew H1 revenue by 20%, lifted ARR by 75% and expanded its order book, giving management greater confidence for 2026.
July 29, 2026
Showing 2 of 3 posts
Diaceutics FY2025: revenue +20% to £38.4m, returns to profitability, record £38.9m order book. Strong growth and margins improving.
JoshuaMay 26, 2026
Diaceutics FY 2024: 39% revenue surge & 50% EBITDA jump. US expansion, PMx adoption & enterprise deals fuel precision medicine dominance. Path to profit clear.
JoshuaMay 13, 2025